Investment Summary

Icos Capital Management B.V. Invests In BioActor BV

On July 25, 2011, growth capital firm Icos Capital Management B.V. invested in consumer products company BioActor BV for 2M EUR

Investment Highlights
  • This is Icos Capital Management B.V.’s 1st transaction in the Consumer Products sector.
  • This is Icos Capital Management B.V.’s largest (disclosed) transaction.
  • This is Icos Capital Management B.V.’s 8th transaction in the Netherlands.

Investment Summary
Date 2011-07-25
Target BioActor BV
Sector Consumer Products
Investor(s) Icos Capital Management B.V.
Deal Type Venture
Deal Value 2M EUR

Target

BioActor BV

Maastricht, Netherlands
BioActor markets health ingredients for dietary supplements and functional foods, on the basis of proprietary bioactives with human clinical evidence that address health concerns related to metabolic syndrome and ageing.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Icos Capital Management B.V.

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2005
PE ASSETS 100M EUR
Size Small
Type Sector Focused
DESCRIPTION

Icos Capital is a specialist private equity firm focused on investments in clean technology. Icos looks for European companies that offer new, alternative scarce resources (water, energy) and more efficient industrial and consumer products. The firm looks to provide growth capital in the form of minority investments. Icos' target investment size is €100K to €2.5 million. Icos Capital is headquartered in Badhoevedorp, Netherlands.

DEAL STATS #
Overall 8 of 9
Sector (Consumer Products) 1 of 1
Type (Venture) 1 of 2
Country (Netherlands) 8 of 9
Year (2011) 3 of 3
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-18 Microdish BV

Utrecht, Netherlands

Microdish delivers an improved platform for microbial culture growth and detection through design, manufacture and use of microengineered culture chips and nanoscale reagents, leading to lower cost, less environmental impact and better (faster, more accurate and controlled) product characteristics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-01 Photanol BV

Amsterdam, Netherlands

The Photanol® produces organic compounds (biofuels/chemicals) directly from cyanobacteria capturing sun light effciently and using that energy for the production (whilst consuming CO2).

Buy -
Mergr

Product

Company

Legal